These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Quantitative topographical EEG compared to FDG PET for classification of vascular and degenerative dementia. Szelies B, Mielke R, Herholz K, Heiss WD. Electroencephalogr Clin Neurophysiol; 1994 Aug; 91(2):131-9. PubMed ID: 7519142 [Abstract] [Full Text] [Related]
7. A comparison of FDG PET and IQNB SPECT in normal subjects and in patients with dementia. Weinberger DR, Jones D, Reba RC, Mann U, Coppola R, Gibson R, Gorey J, Braun A, Chase TN. J Neuropsychiatry Clin Neurosci; 1992 Aug; 4(3):239-48. PubMed ID: 1498576 [Abstract] [Full Text] [Related]
8. Difference of regional cerebral metabolic pattern between presenile and senile dementia of the Alzheimer type: a factor analytic study. Ichimiya A, Herholz K, Mielke R, Kessler J, Slansky I, Heiss WD. J Neurol Sci; 1994 May; 123(1-2):11-7. PubMed ID: 8064302 [Abstract] [Full Text] [Related]
9. Positron emission tomographic studies of aging and Alzheimer disease. de Leon MJ, Ferris SH, George AE, Christman DR, Fowler JS, Gentes C, Reisberg B, Gee B, Emmerich M, Yonekura Y, Brodie J, Kricheff II, Wolf AP. AJNR Am J Neuroradiol; 1983 May; 4(3):568-71. PubMed ID: 6410799 [Abstract] [Full Text] [Related]
10. Impaired metabolic activation in Alzheimer's disease: a PET study during continuous visual recognition. Kessler J, Herholz K, Grond M, Heiss WD. Neuropsychologia; 1991 May; 29(3):229-43. PubMed ID: 2057055 [Abstract] [Full Text] [Related]
11. 18F-2-deoxy-2-fluoro-D-glucose as a tracer in the positron emission tomographic study of senile dementia. Farkas T, Ferris SH, Wolf AP, De Leon MJ, Christman DR, Reisberg B, Alavi A, Fowler JS, George AE, Reivich M. Am J Psychiatry; 1982 Mar; 139(3):352-3. PubMed ID: 6977276 [No Abstract] [Full Text] [Related]
16. Clinical application of positron emission tomography for diagnosis of dementia. Ishii K. Ann Nucl Med; 2002 Dec; 16(8):515-25. PubMed ID: 12593416 [Abstract] [Full Text] [Related]
17. Comparability of FDG PET studies in probable Alzheimer's disease. Herholz K, Perani D, Salmon E, Franck G, Fazio F, Heiss WD, Comar D. J Nucl Med; 1993 Sep; 34(9):1460-6. PubMed ID: 8355064 [Abstract] [Full Text] [Related]
18. European Association of Nuclear Medicine and European Academy of Neurology recommendations for the use of brain 18 F-fluorodeoxyglucose positron emission tomography in neurodegenerative cognitive impairment and dementia: Delphi consensus. Nobili F, Arbizu J, Bouwman F, Drzezga A, Agosta F, Nestor P, Walker Z, Boccardi M, EANM-EAN Task Force for the Prescription of FDG-PET for Dementing Neurodegenerative Disorders. Eur J Neurol; 2018 Oct; 25(10):1201-1217. PubMed ID: 29932266 [Abstract] [Full Text] [Related]
19. Positron emission tomography in the differential diagnosis of organic dementias. Heiss WD, Kessler J, Szelies B, Grond M, Fink G, Herholz K. J Neural Transm Suppl; 1991 Oct; 33():13-9. PubMed ID: 1753242 [Abstract] [Full Text] [Related]
20. Can PET data differentiate Alzheimer's disease from vascular dementia? Nagata K, Maruya H, Yuya H, Terashi H, Mito Y, Kato H, Sato M, Satoh Y, Watahiki Y, Hirata Y, Yokoyama E, Hatazawa J. Ann N Y Acad Sci; 2000 Apr; 903():252-61. PubMed ID: 10818514 [Abstract] [Full Text] [Related] Page: [Next] [New Search]